Related Experiment Video
Updated: Feb 1, 2026

Author Spotlight: Advancements in Understanding and Combatting Shigella Infections
Published on: February 9, 2024
Role of a fluid-phase PRR in fighting an intracellular pathogen: PTX3 in Shigella infection
Valeria Ciancarella1, Luigi Lembo-Fazio1, Ida Paciello1
1Department of Biology and Biotechnology "Charles Darwin", Sapienza-Università di Roma, Laboratory affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Roma, Italy.
Abstract:
Shigella spp. are pathogenic bacteria that cause bacillary dysentery in humans by invading the colonic and rectal mucosa where they induce dramatic inflammation. Here, we have analyzed the role of the soluble PRR Pentraxin 3 (PTX3), a key component of the humoral arm of innate immunity. Mice that had been intranasally infected with S. flexneri were rescued from death by treatment with recombinant PTX3. In vitro PTX3 exerts the antibacterial activity against Shigella, impairing epithelial cell invasion and contributing to the bactericidal activity of serum. PTX3 is produced upon LPS-TLR4 stimulation in accordance with the lipid A structure of Shigella. In the plasma of infected patients, the level of PTX3 amount only correlates strongly with symptom severity. These results signal PTX3 as a novel player in Shigella pathogenesis and its potential role in fighting shigellosis. Finally, we suggest that the plasma level of PTX3 in shigellosis patients could act as a biomarker for infection severity.
Insights
Pentraxin 3 (PTX3) shows antibacterial activity against Shigella, protecting mice from infection. Elevated PTX3 levels in patients correlate with shigellosis severity, suggesting its potential as a therapeutic and diagnostic marker.
Area of Science:
- Immunology
- Microbiology
- Infectious Diseases
Background:
- Shigella spp. cause bacillary dysentery through mucosal invasion and inflammation.
- Pentraxin 3 (PTX3), a soluble pattern recognition receptor, is a key component of innate immunity.
Purpose of the Study:
- To investigate the role of PTX3 in Shigella pathogenesis and its potential therapeutic applications.
- To explore PTX3 as a potential biomarker for shigellosis severity.
Main Methods:
- In vivo studies using intranasal infection of mice with S. flexneri and treatment with recombinant PTX3.
- In vitro assays to assess PTX3's antibacterial activity, epithelial cell invasion inhibition, and serum bactericidal activity.
- Analysis of PTX3 production upon LPS-TLR4 stimulation.
- Correlation analysis of plasma PTX3 levels with symptom severity in infected patients.
Main Results:
- Recombinant PTX3 treatment rescued mice from S. flexneri infection.
- PTX3 demonstrated in vitro antibacterial activity against Shigella, inhibited epithelial cell invasion, and enhanced serum bactericidal activity.
- PTX3 production was induced by LPS-TLR4 stimulation, dependent on Shigella lipid A structure.
- Plasma PTX3 levels strongly correlated with the severity of shigellosis symptoms in patients.
Conclusions:
- PTX3 is a novel factor in Shigella pathogenesis with potential therapeutic benefits against shigellosis.
- Plasma PTX3 levels may serve as a valuable biomarker for assessing shigellosis infection severity.
Related Concept Videos
Phase Diagrams
Intracellular Signaling Cascades
Phase Transitions
The Fluid Mosaic Model
Inductance: Single-Phase And Three-Phase Line
Single-Phase Two-Wire Line:
A single-phase line consists of two solid cylindrical conductors, denoted as x and y. Each conductor carries phasor currents ix and iy, respectively. Given that the sum of these currents is...
Capacitance: Single-Phase And Three-Phase Line
Single-Phase Lines
Consider a single-phase, two-wire transmission line with equal phase spacing energized by a voltage source. One conductor carries a uniform positive charge, while the other carries an equal negative charge. The capacitance C of the line can be derived from the voltage V between the conductors. For a one-meter section of the line, the capacitance is given...

